Ervin K.
- Country
- Denmark
- Department
- Obstetrics and Gynecology
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Breast Oncology
The investigator concentrates on advanced and early‑stage breast cancer therapies, emphasizing molecular subtypes and treatment resistance.
- HER2‑positive disease
- triple‑negative disease
- hormone receptor‑positive disease
- neoadjuvant chemotherapy
- adjuvant endocrine therapy
Research integrates targeted agents and antibody‑drug conjugates to improve invasive disease‑free survival.
Lung Oncology
Focus includes both non‑small cell and small‑cell lung cancer with attention to driver mutations and immunotherapy.
- KRAS G12C mutation
- non‑squamous NSCLC
- PD‑L1 high expression
- checkpoint inhibitor combinations
- relapsed small‑cell disease
Efforts aim to extend overall survival through precision‑targeted and immune‑based regimens.
Cardiovascular & Heart Failure
Investigations target acute and chronic cardiovascular disease, including heart failure phenotypes and post‑myocardial infarction management.
- HFpEF
- HFmrEF
- reduced ejection fraction
- vascular remodeling
- anticoagulation in mechanical valves
Studies assess functional capacity and hospitalization risk to refine therapeutic algorithms.
Obstetrics & Gynecology
Clinical work addresses reproductive emergencies such as ectopic pregnancy and hormonal regulation in early pregnancy.
- medical termination protocols
- progesterone antagonists
- fertility preservation
- pregnancy‑related hypertension
Outcomes focus on safety, efficacy, and preservation of future fertility.
Infectious Diseases & Critical Care
The investigator contributes to management of severe infections and intensive care conditions, notably complicated urinary tract infection and bloodstream infections.
- cUTI
- Staphylococcus aureus bacteremia
- antibiotic duration optimization
- intensive care platform interventions
- mechanical ventilation strategies
Research seeks to reduce mortality and antimicrobial resistance through evidence‑based protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.